A 32-year-old man with bipolar disorder I presents with acute mania characterized by grandiosity, flight of ideas, and decreased need for sleep for 5 days. He has no prior exposure to mood stabilizers. What is the drug of choice for acute mania in this patient?

Question

Accepted Answer

C. Lithium carbonate. ## First-Line Treatment of Acute Mania in Bipolar I Disorder

**Key Point:** Lithium carbonate remains the gold standard and first-line mood stabilizer for acute mania in bipolar disorder I, with the strongest evidence base for efficacy and long-term relapse prevention.

### Lithium: Why It Is First-Line

1. **Efficacy in acute mania**: Onset of action 5–7 days; response rates 60–70% in acute episodes
2. **Gold standard for maintenance**: Reduces relapse risk by ~50% and has anti-suicidal properties
3. **Robust evidence base**: Decades of RCT data and clinical experience
4. **Therapeutic window**: Serum level 0.6–1.2 mEq/L for acute mania; 0.4–0.8 mEq/L for maintenance

### Comparison with Alternatives

| Drug | Onset | Acute Mania | Maintenance | Key Limitation |
|------|-------|------------|-------------|----------------|
| **Lithium** | 5–7 days | Excellent | Excellent | Narrow therapeutic window, renal/thyroid monitoring |
| **Valproate** | 2–4 days | Excellent | Good | Teratogenic, weight gain, hepatotoxicity risk |
| **Lamotrigine** | 2–4 weeks | Weak/ineffective | Good for depression | Poor for acute mania; better for bipolar depression |
| **Carbamazepine** | 3–5 days | Good | Moderate | Drug interactions, autoinduction, rash risk |

**Clinical Pearl:** Valproate has faster onset than lithium (2–4 days vs 5–7 days) and may be preferred in severe, agitated mania or when rapid control is needed; however, lithium remains first-line in stable, first-episode presentations.

**High-Yield:** Lamotrigine is ineffective for acute mania and is reserved for bipolar depression and maintenance; using it alone in acute mania is a common exam trap.

**Mnemonic:** **LAVA** — **L**ithium (first-line), **A**ntipsychotics (adjunct), **V**alproate (alternative), **A**typical antipsychotics (acute + maintenance).

### Monitoring Requirements for Lithium

- Baseline: renal function (creatinine, eGFR), thyroid function (TSH, free T4), ECG
- Therapeutic drug monitoring: serum level at day 5, then weekly until stable
- Ongoing: renal and thyroid function every 6–12 months
- Contraindications: severe renal impairment, pregnancy (especially first trimester — Ebstein anomaly risk)

**Warning:** Do not confuse lithium's role — it is NOT a sedative and does NOT work acutely like benzodiazepines; antipsychotics or benzodiazepines are used for immediate behavioral control, while lithium is started for long-term mood stabilization.

Answer

A. Carbamazepine

Answer

B. Valproate (divalproex sodium)

Answer

D. Lamotrigine

A 32-year-old man with bipolar disorder I presents with acute mania characterized by grandiosity, flight of ideas, and decreased need for sleep for 5 days. He has no prior exposure to mood stabilizers. What is the drug of choice for acute mania in this patient?

Explanation

First-Line Treatment of Acute Mania in Bipolar I Disorder

Lithium: Why It Is First-Line

Comparison with Alternatives

Monitoring Requirements for Lithium

Practice similar questions

Join our NEET PG community

Drug	Onset	Acute Mania	Maintenance	Key Limitation
Lithium	5–7 days	Excellent	Excellent	Narrow therapeutic window, renal/thyroid monitoring
Valproate	2–4 days	Excellent	Good	Teratogenic, weight gain, hepatotoxicity risk
Lamotrigine	2–4 weeks	Weak/ineffective	Good for depression	Poor for acute mania; better for bipolar depression
Carbamazepine	3–5 days	Good	Moderate	Drug interactions, autoinduction, rash risk